Clinical utility gene card for: Maturity-onset diabetes of the young.

Item

http://www.wikidata.org/entity/Q42796379

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Clinical utility gene card for: Maturity-onset diabetes of the young.

@en

Clinical utility gene card for: Maturity-onset diabetes of the young.

@nl

type

Item

label

Clinical utility gene card for: Maturity-onset diabetes of the young.

@en

Clinical utility gene card for: Maturity-onset diabetes of the young.

@nl

prefLabel

Clinical utility gene card for: Maturity-onset diabetes of the young.

@en

Clinical utility gene card for: Maturity-onset diabetes of the young.

@nl

P1476

Clinical utility gene card for: Maturity-onset diabetes of the young.

@en

P2093

Cécile Saint-Martin

http://www.w3.org/2001/XMLSchema#string

José Timsit

http://www.w3.org/2001/XMLSchema#string

Kevin Colclough

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic cause of hyperglycaemia and response to treatment in diabetes

Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene

Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.

Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Exome sequencing and genetic testing for MODY.

Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment

P2888

ejhg.2014.14

P31

scholarly article

P356

10.1038/EJHG.2014.14

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sian Ellard

Christine Bellanné-Chantelot

P577

2014-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260148982

http://www.w3.org/2001/XMLSchema#string

P6179

1051528730

http://www.w3.org/2001/XMLSchema#string

P698

24518839

http://www.w3.org/2001/XMLSchema#string

P932

4135417

http://www.w3.org/2001/XMLSchema#string